Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients"

J Hepatol. 2021 Jul;75(1):228-229. doi: 10.1016/j.jhep.2021.04.005. Epub 2021 Apr 20.
No abstract available

Keywords: COVID-19; SARS-CoV-2; calcineurin inhibitors; everolimus; immunosuppression; mycophenolate; pneumonia; tacrolimus; transplantation.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Calcineurin Inhibitors
  • Comorbidity
  • Humans
  • Immunosuppressive Agents
  • Liver Transplantation*
  • SARS-CoV-2

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents